BioAtla (BCAB) Other Accumulated Expenses (2020 - 2026)
BioAtla's Other Accumulated Expenses came in at $384,000 for Q2 2026, down 46.3% from $715,000 a year earlier and down 59.2% from the prior quarter.
Powered by 
Analysis
BioAtla (BCAB) Other Accumulated Expenses (2020 - 2026) Analysis & Trends
At the end of FY2025, BioAtla's Other Accumulated Expenses was $879,000, down 15.7% from FY2024.
- Other Accumulated Expenses carries a five-year compound annual growth rate of 1.6% (FY2020 to FY2025).
- Going back by year, Other Accumulated Expenses was $1.04 million in FY2024 (+20.6%), $865,000 in FY2023 (-32.4%), $1.28 million in FY2022 (+19.2%) and $1.07 million in FY2021 (+32.0%).
- The Q2 2026 figure represents the lowest quarterly Other Accumulated Expenses in data going back to Q4 2020.
- Year-over-year, Other Accumulated Expenses increased in five of the last eight quarters, with growth averaging 9.3%.
- The fastest year-over-year change in Other Accumulated Expenses over five years came in Q2 2022 (growth of 181.5%), and the weakest in Q2 2023 (a decline of 50.6%).
- Business Quant data shows BCAB's Other Accumulated Expenses at $941,000 (Q1 2026), $879,000 (Q4 2025) and $509,000 (Q3 2025) in the three quarters before Q2 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Eli Lilly | 1,076.25 Bn | 1,044.84 Bn | 19.71 Bn |
| 2 | Johnson & Johnson | 617.18 Bn | 535.70 Bn | 17.26 Bn |
| 3 | AbbVie | 464.58 Bn | 437.73 Bn | 12.70 Bn |
| 4 | Merck | 356.04 Bn | 310.47 Bn | 12.21 Bn |
| 5 | Novartis Ag | 269.07 Bn | 224.94 Bn | 11.24 Bn |
| 6 | Astrazeneca | 243.21 Bn | 216.77 Bn | 12.86 Bn |
| 7 | Amgen | 217.88 Bn | 173.28 Bn | 7.24 Bn |
| 8 | Gilead Sciences | 179.62 Bn | 153.74 Bn | 6.22 Bn |
| 9 | Pfizer | 158.45 Bn | 105.40 Bn | 10.94 Bn |
| 10 | BioAtla | 2.74 Mn | 2.74 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 384,000.00 |
| Mar 31, 2026 | 941,000.00 |
| Dec 31, 2025 | 879,000.00 |
| Sep 30, 2025 | 509,000.00 |
| Jun 30, 2025 | 715,000.00 |
| Mar 31, 2025 | 898,000.00 |
| Dec 31, 2024 | 1.04 Mn |
| Sep 30, 2024 | 786,000.00 |
| Jun 30, 2024 | 562,000.00 |
| Mar 31, 2024 | 517,000.00 |
| Dec 31, 2023 | 865,000.00 |
| Sep 30, 2023 | 542,000.00 |
| Jun 30, 2023 | 879,000.00 |
| Mar 31, 2023 | 707,000.00 |
| Dec 31, 2022 | 1.28 Mn |
| Sep 30, 2022 | 939,000.00 |
| Jun 30, 2022 | 1.78 Mn |
| Mar 31, 2022 | 847,000.00 |
| Dec 31, 2021 | 1.07 Mn |
| Sep 30, 2021 | 551,000.00 |
API Access
BioAtla Other Accumulated Expenses API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=other-accumulated-expenses&ticker=BCAB&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "other-accumulated-expenses", "ticker": "BCAB", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=other-accumulated-expenses&ticker=BCAB&period=max&api_key=YOUR_API_KEY");
const data = await res.json();